234 related articles for article (PubMed ID: 26753750)
1. Postoperative Infectious Complications are Associated with Adverse Oncologic Outcomes in Esophageal Cancer Patients Undergoing Preoperative Chemotherapy.
Yamashita K; Makino T; Miyata H; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2016 Jun; 23(6):2106-14. PubMed ID: 26753750
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors in Patients Receiving Neoadjuvant 5-Fluorouracil plus Cisplatin for Advanced Esophageal Cancer (JCOG9907).
Yokota T; Ando N; Igaki H; Shinoda M; Kato K; Mizusawa J; Katayama H; Nakamura K; Fukuda H; Kitagawa Y
Oncology; 2015; 89(3):143-51. PubMed ID: 25895447
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
4. The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer.
Kano K; Aoyama T; Yoshikawa T; Maezawa Y; Nakajima T; Hayashi T; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Cho H; Ogata T
Ann Surg Oncol; 2018 Jul; 25(7):2034-2043. PubMed ID: 29748890
[TBL] [Abstract][Full Text] [Related]
5. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.
Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S
Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Postoperative Complications in 502 Patients With Surgically Resected Esophageal Squamous Cell Carcinoma: A Retrospective Single-institution Study.
Baba Y; Yoshida N; Shigaki H; Iwatsuki M; Miyamoto Y; Sakamoto Y; Watanabe M; Baba H
Ann Surg; 2016 Aug; 264(2):305-11. PubMed ID: 26670288
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcome of Esophagectomy in Elderly Patients With and Without Neoadjuvant Therapy for Thoracic Esophageal Cancer.
Miyata H; Yamasaki M; Makino T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S794-801. PubMed ID: 26224407
[TBL] [Abstract][Full Text] [Related]
8. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.
Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H
World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738
[TBL] [Abstract][Full Text] [Related]
10. Influence of preoperative chemotherapy for advanced thoracic oesophageal squamous cell carcinoma on perioperative complications.
Hirao M; Ando N; Tsujinaka T; Udagawa H; Yano M; Yamana H; Nagai K; Mizusawa J; Nakamura K;
Br J Surg; 2011 Dec; 98(12):1735-41. PubMed ID: 21918956
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Postoperative Chylothorax After Radical Subtotal Esophagectomy.
Ohkura Y; Ueno M; Shindoh J; Iizuka T; Ka H; Udagawa H
Ann Surg Oncol; 2018 Sep; 25(9):2739-2746. PubMed ID: 29998406
[TBL] [Abstract][Full Text] [Related]
12. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
13. Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer.
Fujiwara H; Shiozaki A; Konishi H; Kosuga T; Komatsu S; Ichikawa D; Okamoto K; Otsuji E
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859387
[TBL] [Abstract][Full Text] [Related]
14. Impact of body mass index on postoperative complications and long-term survival in patients with esophageal squamous cell cancer.
Kamachi K; Ozawa S; Hayashi T; Kazuno A; Ito E; Makuuchi H
Dis Esophagus; 2016 Apr; 29(3):229-35. PubMed ID: 25789403
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer: Exploratory Analysis of JCOG9907.
Kataoka K; Takeuchi H; Mizusawa J; Igaki H; Ozawa S; Abe T; Nakamura K; Kato K; Ando N; Kitagawa Y
Ann Surg; 2017 Jun; 265(6):1152-1157. PubMed ID: 27280509
[TBL] [Abstract][Full Text] [Related]
16. Postoperative Bleeding After Esophagectomy for Esophageal Cancer in Patients Receiving Antiplatelet and Anticoagulation Treatment.
Aoyama T; Atsumi Y; Hara K; Kazama K; Tamagawa H; Tamagawa A; Komori K; Maezawa Y; Kano K; Hashimoto I; Oshima T; Murakawa M; Numata M; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2359-2364. PubMed ID: 32234938
[TBL] [Abstract][Full Text] [Related]
17. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
18. [Association of postoperative outcome with fasting plasma glucose and risk factors in esophageal squamous cell carcinoma].
Duan X; Gong L; Shang X; Jiang H; Tang P; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):1004-1008. PubMed ID: 27680068
[TBL] [Abstract][Full Text] [Related]
19. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between Intense Postoperative Inflammatory Response and Survival of Esophageal Cancer Patients Who Underwent Transthoracic Esophagectomy.
Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Kitagawa Y
Ann Surg Oncol; 2015 Dec; 22(13):4453-60. PubMed ID: 25893412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
